BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 12208228)

  • 1. Efficacy of a dual chamber defibrillator with atrial antitachycardia functions in treating spontaneous atrial tachyarrhythmias in patients with life-threatening ventricular tachyarrhythmias.
    Ricci R; Pignalberi C; Disertori M; Capucci A; Padeletti L; Botto G; Toscano S; Miraglia F; Grammatico A; Santini M
    Eur Heart J; 2002 Sep; 23(18):1471-9. PubMed ID: 12208228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.
    Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ
    Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience with a dual-chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias.
    Gold MR; Sulke N; Schwartzman DS; Mehra R; Euler DE;
    J Cardiovasc Electrophysiol; 2001 Nov; 12(11):1247-53. PubMed ID: 11761411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Worldwide clinical experience with a new dual-chamber implantable cardioverter defibrillator system.
    Schoels W; Swerdlow CD; Jung W; Stein KM; Seidl K; Haffajee CJ;
    J Cardiovasc Electrophysiol; 2001 May; 12(5):521-8. PubMed ID: 11386511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of atrial antitachycardia functions for treating atrial fibrillation: observations in patients with a dual-chamber defibrillator.
    Ricci R; Pignalberi C; Santini M
    Card Electrophysiol Rev; 2003 Dec; 7(4):348-51. PubMed ID: 15071251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical evaluation of a dual chamber implantable cardioverter-defibrillator].
    Kazmierczak J; Tavernier R; De Sutter J; Jordaens L
    Pol Merkur Lekarski; 2000 Aug; 9(50):522-6. PubMed ID: 11081315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a dual chamber implantable cardioverter defibrillator for the treatment of atrial and ventricular arrhythmias.
    Boriani G; Wollmann C; Biffi M; Kühl M; Schuchert A; Sperzel J; Stiller S; Gasparini G; Böcker D
    Pacing Clin Electrophysiol; 2003 Jan; 26(1P2):461-5. PubMed ID: 12687868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial fibrillation increases the risk of recurrent ventricular tachyarrhythmias in implantable cardioverter defibrillator recipients.
    Rusnak J; Behnes M; Reiser L; Schupp T; Bollow A; Reichelt T; Borggrefe M; Ellguth D; Engelke N; El-Battrawy I; Ansari U; Barre M; Weidner K; Müller J; Barth C; Meininghaus DG; Akin M; Bertsch T; Taton G; Akin I
    Arch Cardiovasc Dis; 2021; 114(6-7):443-454. PubMed ID: 33967015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with implantable atrial and combined atrioventricular defibrillators.
    Jung W; Wolpert C; Esmailzadeh B; Spehl S; Herwig S; Schumacher B; Lewalter T; Omran H; Schimpf R; Vahlhaus C; Welz A; Lüderitz B
    J Interv Card Electrophysiol; 2000 Jan; 4 Suppl 1():185-95. PubMed ID: 10590507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inappropriate cardioverter-defibrillator discharge continues to be a major problem in clinical practice.
    Jodko Ł; Kornacewicz-Jach Z; Kaźmierczak J; Rzeuski R; Zielonka J; Kaliszczak R; Safranow K
    Cardiol J; 2009; 16(5):432-9. PubMed ID: 19753522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of supraventricular tachyarrhythmias in patients with implanted pacing cardioverter defibrillators.
    Schmitt C; Montero M; Melichercik J
    Pacing Clin Electrophysiol; 1994 Mar; 17(3 Pt 1):295-302. PubMed ID: 7513854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A new dual-chamber defibrillation system: duration, frequency and circadian variation of recurrent supraventricular tachyarrhythmias].
    Wolpert C; Jung W; Herwig S; Schimpf R; Lüderitz B
    Herz; 2001 Feb; 26(1):55-63. PubMed ID: 11258110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH; Yee R; Jung W
    J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term multicenter experience with a second-generation implantable pacemaker-defibrillator in patients with malignant ventricular tachyarrhythmias. The Guardian Multicenter Investigators Group.
    Saksena S; Poczobutt-Johanos M; Castle LW; Fogoros RN; Alpert BL; Kron J; Pacifico A; Griffin J; Ruskin JN; Kehoe RF
    J Am Coll Cardiol; 1992 Mar; 19(3):490-9. PubMed ID: 1537999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial clinical experience with endocardial defibrillation using an implantable cardioverter/defibrillator with a triple-electrode system.
    Saksena S; Tullo NG; Krol RB; Mauro AM
    Arch Intern Med; 1989 Oct; 149(10):2333-9. PubMed ID: 2802898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of pacing therapies for treating atrial tachyarrhythmias in patients with ventricular arrhythmias receiving a dual-chamber implantable cardioverter defibrillator.
    Adler SW; Wolpert C; Warman EN; Musley SK; Koehler JL; Euler DE
    Circulation; 2001 Aug; 104(8):887-92. PubMed ID: 11514374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indications for dual-chamber cardioverter defibrillators at implant and at 1 year follow-up: a retrospective analysis in the single-chamber defibrillator era.
    Proclemer A; Della Bella P; Facchin D; Fattore L; Carbucicchio C; Tondo C; Lunati M; Vecchi MR; Petz E; Zecchin M
    Europace; 2001 Apr; 3(2):132-5. PubMed ID: 11333050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable implantable cardioverter-defibrillator implanted with or without thoracotomy: an international multicenter study. PCD Investigator Group.
    J Am Coll Cardiol; 1994 Jun; 23(7):1521-30. PubMed ID: 8195508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual chamber implantable cardioverter defibrillator benefits and limitations.
    Fan K; Lee K; Lau CP
    J Interv Card Electrophysiol; 1999 Oct; 3(3):239-45. PubMed ID: 10490480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of ventricular tachyarrhythmia by treatment of atrial fibrillation in ICD patients with dual-chamber implantable cardioverter/defibrillators capable of atrial therapy delivery: the REVERT-AF Study.
    Gradaus R; Seidl K; Korte T; Himmrich E; Wieneke H; Schuchert A; Bauer W; Gerss J; Wollmann CG; Borggrefe M; Böcker D
    Europace; 2007 Jul; 9(7):534-9. PubMed ID: 17440005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.